Daniel T. Schmid
Dr. med.
Facharzt FMH Radiologie und
Nuklearmedizin
Kernkompetenzen
- Bildgebung bei onkologischen Fragestellungen mittels PET/CT, CT, MRI, Szintigraphien
- Allgemeine Radiologie, CT-gesteuerte Infiltrationen
- Ultraschall- und CT-gesteuerte Biopsien
| 1995-2001 | Studium der Humanmedizin, Universität Zürich |
| 2001-2004 | Assistenzarzt Klinik und Poliklinik für Nuklearmedizin, Universitätsspital Zürich |
| 2004-2007 | Assistenzarzt Institut für Diagnostische Radiologie, Kantonsspital Winterthur |
| 2008-2009 | Assistenzarzt Institut für Diagnostische Radiologie, Universitätsspital Zürich |
| 2009 | Assistenzarzt Klinik für Nuklearmedizin, Universitätsspital Zürich |
| 2009-2012 | Oberarzt Klinik für Nuklearmedizin und Institut für Diagnostische Radiologie, Universitätsspital Zürich |
| Seit 1.7.2012 | am Medizinisch Radiologischen Institut MRI |
- Deutsch
- Englisch
- Französisch
- Schweizerische Gesellschaft für Radiologie (SGR-SSR)
- Schweizerische Gesellschaft für Nuklearmedizin (SGNM)
- European Society of Nuclear Medicine (EANM)
- European Society of Radiology (ESR)
- Verbindung der Schweizer Ärztinnen und Ärzte (FMH)
- Ärztegesellschaft des Kantons Zürich (AGZ)
- Gastrointestinales Tumorzentrum Zürich (GITZ)
1. Originalarbeiten
Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake?
Haerle SK, Hany TF, Ahmad N, Burger I, Huber GF, Schmid DT.
Cancer Imaging. 2013 Feb 20;13:1-7. doi: 10.1102/1470-7330.2013.0001.
Bisphosphonate-induced osteonecrosis of the jaw: comparison of disease extent on contrast-enhanced MR imaging, [18F] fluoride PET/CT, and conebeam CT imaging.
Guggenberger R, Fischer DR, Metzler P, Andreisek G, Nanz D, Jacobsen C, Schmid DT.
AJNR Am J Neuroradiol. 2013 Jun-Jul;34(6):1242-7. doi: 10.3174/ajnr.A3355. Epub 2012 Dec 6.
Discrimination and anatomical mapping of PET-positive lesions: comparison of CT attenuation-corrected PET images with coregistered MR and CT images in the abdomen.
Kuhn FP, Crook DW, Mader CE, Appenzeller P, von Schulthess GK, Schmid DT.
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):44-51. doi: 10.1007/s00259-012-2236-3. Epub 2012 Sep 7.
PET/MR imaging of bone lesions–implications for PET quantification from imperfect attenuation correction.
Samarin A, Burger C, Wollenweber SD, Crook DW, Burger IA, Schmid DT, von Schulthess GK, Kuhn FP.
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1154-60. doi: 10.1007/s00259-012-2113-0. Epub 2012 Apr 14.
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.
Soyka JD, Muster MA, Schmid DT, Seifert B, Schick U, Miralbell R, Jorcano S, Zaugg K, Seifert HH, Veit-Haibach P, Strobel K, Schaefer NG, Husarik DB, Hany TF.
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):936-43. doi: 10.1007/s00259-012-2083-2. Epub 2012 Mar 14.
Improved treatment outcomes with (18) F-FDG PET/CT for patients with advanced head and neck squamous cell carcinoma.
Haerle SK, Soyka MB, Schmid DT, Ahmad N, Huber GF, Crook DW, Hany TF.
Head Neck. 2012 Sep;34(9):1205-11. doi: 10.1002/hed.21887. Epub 2011 Oct 29.
Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine.
Burger IA, Husmann L, Hany TF, Schmid DT, Schaefer NG.
Clin Nucl Med. 2011 Oct;36(10):848-53. doi: 10.1097/RLU.0b013e3182177322.
The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Haerle SK, Schmid DT, Ahmad N, Hany TF, Stoeckli SJ.
Oral Oncol. 2011 Jul;47(7):653-9. doi: 10.1016/j.oraloncology.2011.05.011. Epub 2011 Jun 11.
18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT.
Haerle SK, Fischer DR, Schmid DT, Ahmad N, Huber GF, Buck A.
Mol Imaging Biol. 2011 Oct;13(5):1036-42. doi: 10.1007/s11307-010-0419-5.
Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
Haerle SK, Huber GF, Hany TF, Ahmad N, Schmid DT.
Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1635-40. doi: 10.1007/s00405-010-1348-2. Epub 2010 Aug 3.
Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases.
Haerle SK, Strobel K, Ahmad N, Soltermann A, Schmid DT, Stoeckli SJ.
Head Neck. 2011 Mar;33(3):324-9. doi: 10.1002/hed.21447.
Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine.
Soyka JD, Strobel K, Veit-Haibach P, Schaefer NG, Schmid DT, Tschopp A, Hany TF.
J Nucl Med. 2010 Apr;51(4):507-10. doi: 10.2967/jnumed.109.071001. Epub 2010 Mar 17.
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
Gutzeit A, Doert A, Froehlich JM, Eckhardt BP, Meili A, Scherr P, Schmid DT, Graf N, von Weymarn CA, Willemse EM, Binkert CA.
Skeletal Radiol. 2010 Apr;39(4):333-43. doi: 10.1007/s00256-009-0789-4.
Fatty muscle atrophy: prevalence in the hindfoot muscles on MR images of asymptomatic volunteers and patients with foot pain.
Schmid DT, Hodler J, Mengiardi B, Pfirrmann CW, Espinosa N, Zanetti M.
Radiology. 2009 Oct;253(1):160-6. doi: 10.1148/radiol.2531090035. Epub 2009 Jul 31.
Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
Goerres GW, Schuknecht B, Schmid DT, Stoeckli SJ, Hany TF.
Clin Imaging. 2008 Nov-Dec;32(6):431-7. doi: 10.1016/j.clinimag.2008.04.012.
3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate.
Ciernik IF, Brown DW, Schmid D, Hany T, Egli P, Davis JB.
Technol Cancer Res Treat. 2007 Feb;6(1):23-30.
Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT.
Goerres GW, Schmid DT, Schuknecht B, Eyrich GK.
Radiology. 2005 Oct;237(1):281-7. Epub 2005 Aug 18. Erratum in: Radiology. 2006 Apr;239(1):303.
Fluorocholine PET/CT in patients with prostate cancer: initial experience.
Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, von Schulthess GK, Hany TF.
Radiology. 2005 May;235(2):623-8.
Do hardware artefacts influence the performance of head and neck PET scans in patients with oral cavity squamous cell cancer?
Goerres GW, Schmid DT, Eyrich GK.
Dentomaxillofac Radiol. 2003 Nov;32(6):365-71.
Positron emission tomography in the early follow-up of advanced head and neck cancer.
Goerres GW, Schmid DT, Bandhauer F, Huguenin PU, von Schulthess GK, Schmid S, Stoeckli SJ.
Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):105-9; discussion 120-1.
Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
Goerres GW, Schmid DT, Grätz KW, von Schulthess GK, Eyrich GK.
Oral Oncol. 2003 Sep;39(6):547-51.
Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
Schmid DT, Stoeckli SJ, Bandhauer F, Huguenin P, Schmid S, von Schulthess GK, Goerres GW.
Laryngoscope. 2003 May;113(5):888-91.
2. Fallbeschreibungen (Case Reports)
Pain-related F-18 FDG uptake of the corrugator supercilii muscles in PET/CT.
Burger IA, Schmid DT, Hany TF.
Clin Nucl Med. 2012 Jan;37(1):e11-2. doi: 10.1097/RLU.0b013e318233641f.
Increased 18F-FDG uptake mimicking thyroid cancer in a patient with Hashimoto’s thyroiditis.
Schmid DT, Kneifel S, Stoeckli SJ, Padberg BC, Merrill G, Goerres GW.
Eur Radiol. 2003 Sep;13(9):2119-21. Epub 2002 Aug 30.